Literature DB >> 21775962

Mouse bladder wall injection.

Chi-Ling Fu1, Charity A Apelo, Baldemar Torres, Kim H Thai, Michael H Hsieh.   

Abstract

Mouse bladder wall injection is a useful technique to orthotopically study bladder phenomena, including stem cell, smooth muscle, and cancer biology. Before starting injections, the surgical area must be cleaned with soap and water and antiseptic solution. Surgical equipment must be sterilized before use and between each animal. Each mouse is placed under inhaled isoflurane anesthesia (2-5% for induction, 1-3% for maintenance) and its bladder exposed by making a midline abdominal incision with scissors. If the bladder is full, it is partially decompressed by gentle squeezing between two fingers. The cell suspension of interest is intramurally injected into the wall of the bladder dome using a 29 or 30 gauge needle and 1 cc or smaller syringe. The wound is then closed using wound clips and the mouse allowed to recover on a warming pad. Bladder wall injection is a delicate microsurgical technique that can be mastered with practice.

Entities:  

Mesh:

Year:  2011        PMID: 21775962      PMCID: PMC3196188          DOI: 10.3791/2523

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  14 in total

1.  Preliminary results of myoblast injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontinence and impaired detrusor contractility.

Authors:  M B Chancellor; T Yokoyama; S Tirney; C E Mattes; H Ozawa; N Yoshimura; W C de Groat; J Huard
Journal:  Neurourol Urodyn       Date:  2000       Impact factor: 2.696

2.  Establishment and characterization of a new human bladder cancer cell line showing features of squamous and glandular differentiation.

Authors:  P J Russell; M Jelbart; E Wills; S Singh; J Wass; J Wotherspoon; D Raghavan
Journal:  Int J Cancer       Date:  1988-01-15       Impact factor: 7.396

3.  Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule.

Authors:  J W Slaton; P Perrotte; K Inoue; C P Dinney; I J Fidler
Journal:  Clin Cancer Res       Date:  1999-10       Impact factor: 12.531

4.  The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumors.

Authors:  Khalid A Mohamedali; Daniel Kedar; Paul Sweeney; Ashish Kamat; Darren W Davis; Beryl Y Eve; Samuel Huang; Philip E Thorpe; Colin P Dinney; Michael G Rosenblum
Journal:  Neoplasia       Date:  2005-10       Impact factor: 5.715

5.  Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis.

Authors:  Ajita V Singh; Adrian A Franke; George L Blackburn; Jin-Rong Zhou
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

6.  Intravesical liposomal muramyl tripeptide phosphatidylethanolamine treatment of human bladder carcinoma growing in nude mice.

Authors:  C P Dinney; S Tanguay; C D Bucana; B Y Eve; I J Fidler
Journal:  J Interferon Cytokine Res       Date:  1995-06       Impact factor: 2.607

Review 7.  Mouse orthotopic models for bladder cancer research.

Authors:  Eddie Chan; Amit Patel; Warren Heston; William Larchian
Journal:  BJU Int       Date:  2009-04-16       Impact factor: 5.588

8.  Modulation of the microenvironment by growth factors regulates the in vivo growth of skeletal myoblasts.

Authors:  Akihiro Yanagiuchi; Hideaki Miyake; Masashi Nomi; Atsushi Takenaka; Masato Fujisawa
Journal:  BJU Int       Date:  2009-06       Impact factor: 5.588

9.  Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice.

Authors:  C P Dinney; R Fishbeck; R K Singh; B Eve; S Pathak; N Brown; B Xie; D Fan; C D Bucana; I J Fidler
Journal:  J Urol       Date:  1995-10       Impact factor: 7.450

10.  Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cells.

Authors:  H Miyake; I Hara; K Yamanaka; K Gohji; S Arakawa; S Kamidono
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

View more
  17 in total

1.  An orthotopic bladder tumor model and the evaluation of intravesical saRNA treatment.

Authors:  Moo Rim Kang; Glen Yang; Klaus Charisse; Hila Epstein-Barash; Muthiah Manoharan; Long-Cheng Li
Journal:  J Vis Exp       Date:  2012-07-28       Impact factor: 1.355

2.  Interleukin-4 Signaling Plays a Major Role in Urogenital Schistosomiasis-Associated Bladder Pathogenesis.

Authors:  Evaristus C Mbanefo; Chi-Ling Fu; Christina P Ho; Loc Le; Kenji Ishida; Olfat Hammam; Michael H Hsieh
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

3.  Schistosoma haematobium cercarial infection alters subsequent systemic immune responses to eggs but has minimal impact on immune responses to egg injection of the bladder.

Authors:  Le Loc; Evaristus C Mbanefo; George Khludenev; Olivia Lamanna; Nirad Banskota; Michael H Hsieh
Journal:  Parasite Immunol       Date:  2018-12-03       Impact factor: 2.280

4.  Designer aminoglycosides prevent cochlear hair cell loss and hearing loss.

Authors:  Markus E Huth; Kyu-Hee Han; Kayvon Sotoudeh; Yi-Ju Hsieh; Thomas Effertz; Andrew A Vu; Sarah Verhoeven; Michael H Hsieh; Robert Greenhouse; Alan G Cheng; Anthony J Ricci
Journal:  J Clin Invest       Date:  2015-01-02       Impact factor: 14.808

5.  Macrophages are required for host survival in experimental urogenital schistosomiasis.

Authors:  Chi-Ling Fu; Justin I Odegaard; Michael H Hsieh
Journal:  FASEB J       Date:  2014-10-28       Impact factor: 5.191

6.  Schistosoma haematobium egg-induced bladder urothelial abnormalities dependent on p53 are modulated by host sex.

Authors:  Jared Honeycutt; Olfat Hammam; Michael H Hsieh
Journal:  Exp Parasitol       Date:  2015-07-06       Impact factor: 2.011

Review 7.  Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer.

Authors:  Jared Honeycutt; Olfat Hammam; Chi-Ling Fu; Michael H Hsieh
Journal:  Trends Parasitol       Date:  2014-06-06

8.  Sigma S-dependent antioxidant defense protects stationary-phase Escherichia coli against the bactericidal antibiotic gentamicin.

Authors:  Jing-Hung Wang; Rachna Singh; Michael Benoit; Mimi Keyhan; Matthew Sylvester; Michael Hsieh; Anuradha Thathireddy; Yi-Ju Hsieh; A C Matin
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

9.  Helminth-induced interleukin-4 abrogates invariant natural killer T cell activation-associated clearance of bacterial infection.

Authors:  Yi-Ju Hsieh; Chi-Ling Fu; Michael H Hsieh
Journal:  Infect Immun       Date:  2014-03-18       Impact factor: 3.441

10.  Schistosoma haematobium Egg Isolation.

Authors:  Chi-Ling Fu; Michael H Hsieh
Journal:  Bio Protoc       Date:  2012-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.